1. Home
  2. CSBR vs PDCC Comparison

CSBR vs PDCC Comparison

Compare CSBR & PDCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CSBR
  • PDCC
  • Stock Information
  • Founded
  • CSBR 1985
  • PDCC N/A
  • Country
  • CSBR United States
  • PDCC
  • Employees
  • CSBR N/A
  • PDCC N/A
  • Industry
  • CSBR Biotechnology: Biological Products (No Diagnostic Substances)
  • PDCC
  • Sector
  • CSBR Health Care
  • PDCC
  • Exchange
  • CSBR Nasdaq
  • PDCC NYSE
  • Market Cap
  • CSBR 113.0M
  • PDCC 123.0M
  • IPO Year
  • CSBR 1986
  • PDCC N/A
  • Fundamental
  • Price
  • CSBR $8.24
  • PDCC $17.02
  • Analyst Decision
  • CSBR Strong Buy
  • PDCC
  • Analyst Count
  • CSBR 1
  • PDCC 0
  • Target Price
  • CSBR $12.00
  • PDCC N/A
  • AVG Volume (30 Days)
  • CSBR 38.4K
  • PDCC N/A
  • Earning Date
  • CSBR 07-17-2025
  • PDCC N/A
  • Dividend Yield
  • CSBR N/A
  • PDCC N/A
  • EPS Growth
  • CSBR N/A
  • PDCC N/A
  • EPS
  • CSBR 0.46
  • PDCC N/A
  • Revenue
  • CSBR $58,591,000.00
  • PDCC N/A
  • Revenue This Year
  • CSBR $15.11
  • PDCC N/A
  • Revenue Next Year
  • CSBR $7.80
  • PDCC N/A
  • P/E Ratio
  • CSBR $17.82
  • PDCC N/A
  • Revenue Growth
  • CSBR 19.03
  • PDCC N/A
  • 52 Week Low
  • CSBR $3.60
  • PDCC N/A
  • 52 Week High
  • CSBR $11.99
  • PDCC N/A
  • Technical
  • Relative Strength Index (RSI)
  • CSBR 69.99
  • PDCC N/A
  • Support Level
  • CSBR $6.27
  • PDCC N/A
  • Resistance Level
  • CSBR $8.58
  • PDCC N/A
  • Average True Range (ATR)
  • CSBR 0.64
  • PDCC 0.00
  • MACD
  • CSBR 0.28
  • PDCC 0.00
  • Stochastic Oscillator
  • CSBR 96.63
  • PDCC 0.00

About CSBR Champions Oncology Inc.

Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. The company's revenue is majorly derived from research services.

About PDCC PEARL DIVER CREDIT COMPANY INC

PEARL DIVER CREDIT COMPANY INC is an externally managed, non-diversified, closed-end management investment company. Its primary investment objective is to generate high current income, with a secondary objective to generate capital appreciation by investing predominantly in third-party Collateralized Loan Obligation (CLO) equity and mezzanine tranches of predominately U.S.-dollar-denominated CLOs backed by corporate leveraged loans issued mainly to U.S. obligors.

Share on Social Networks: